Company Profiles

driven by the PitchBook Platform

American Gene Technologies International

American Gene Technologies International
2007 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Angel LATEST DEAL TYPE
$1.16M LATEST DEAL AMOUNT
$2.83M TOTAL AMOUNT RAISED
Description

Developer of bio-safe lentivirus therapies designed to treat cancer, metabolic disorders and infectious diseases. The company's lentivirus therapies incorporate a novel, proprietary technology for the clinical application of gene expression technology in cancer therapy, autosomal disorders, stem cell treatment and other applications, enabling patients to begin their treatment more quickly and result in a higher likelihood of a successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
15010 Broschart Road
Suite 110
Rockville, MD 20850
United States

+1 (301) 337-2100
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore American Gene Technologies International’s full profile, request a free trial.

American Gene Technologies International Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 10-Nov-2015 $1.16M $2.83M Completed Generating Revenue
3. Angel (individual) 03-Oct-2014 00000 00.000 Completed Generating Revenue
2. Seed Round 16-Sep-2013 $1.32M $1.32M Completed Generating Revenue
1. Grant 01-Apr-2012 $182k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

American Gene Technologies International Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Institutes of Health Government 000 0000 000000 0

You’re viewing 1 of 1 investors.

American Gene Technologies International Executive Team (7)

Name Title Board
Seat
Contact
Info
Jeffrey Galvin Co-Founder, Chief Executive Officer and Board Member
Shannah Koss Chief Operating Officer
John Matthews Chief Strategy Officer
David Pauza Chief Science Officer
Dan Sussman Ph.D Vice President of Research & Development
You’re viewing 5 of 7 executives. Get the full list »

American Gene Technologies International Board Members (3)

Name Representing Role Since Contact
Info
Aaron Galvin American Gene Technologies International Board Member 000 0000
Qi Tang American Gene Technologies International Board Member 000 0000
Stuart Baker American Gene Technologies International Board Member 000 0000

You’re viewing 3 of 3 board members.